Status:
COMPLETED
Luteal Phase Support During Frozen Embryo Transfer Cycle
Lead Sponsor:
Royan Institute
Conditions:
Infertility, Female
Frozen Embryo Transfer
Eligibility:
FEMALE
21-37 years
Phase:
PHASE3
Brief Summary
We aimed to decrease quantity of exogenous estrogen and evaluated the success rate of ongoing pregnancy in women undergone artificial FET who have a surplus embryos at previous fertility treatment cyc...
Detailed Description
Approval Status: Confirmed Approval reference Number: IR.ACECR.ROYAN.REC.1395.70 Board Name: Ethics committee of Royan infertility institute Board Affiliation: Reza Samani Phone: +982122305236 Email: ...
Eligibility Criteria
Inclusion
- Patients with surplus embryos undergone infertility treatment cycles (e.g. OHSS, inadequate endometrium, surplus frozen embryo from any cause)
- Age 21-37 years
- Normal BMI (18.5 \<BMI \<30)
- IVF / ICSI or IVF or ICSI cycles with antagonists or agonists protocols
- Frozen embryos on 2-3 days
Exclusion
- Endometrial thickness ≤7mm
- Egg Donors
- Surrogacy
- Male factor infertility with azoospermia
- Age \<37 years old
- Hydrosalpinx
- Uterine anomalies
- Myoma with a compression effect or submocusa myoma
- PGD
- Blastocyst embryo transfer, ZIFT and GIFT
Key Trial Info
Start Date :
November 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2019
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04013438
Start Date
November 1 2017
End Date
April 30 2019
Last Update
July 9 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royan Institute
Tehran, Iran